Mallinckrodt Finds An Exit Door For Generics In Proposed Opioid Settlement
Executive Summary
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.